Sanofi Consumer Healthcare P/B Ratio
Sanofi Consumer Healthcare (SANOFICONR) P/B ratio is 27.2 (High), book value per share ₹166.96 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Explore SANOFICONR true value to estimate fundamental worth using multiple valuation models.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
SANOFICONR P/B Ratio — Valuation Insights & Book Value Analysis
Sanofi Consumer Healthcare price-to-book ratio interpretation, valuation status and historical context — current P/B 27.2 (High). For live price, earnings yield and the full fundamental profile, see Sanofi Consumer Healthcare share price today.
- Stock appears overvalued with PB of 27.2, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 20.7% below historical average
- Trading at premium to sector average PB of -0.01
Sanofi Consumer Healthcare P/B Ratio Historical Trend
SANOFICONR annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Read SANOFICONR dividend payout details for the complete payout history and dividend yield track record.
SANOFICONR Historical P/B Ratio — Book Value Per Share & Year-End Price
Sanofi Consumer Healthcare annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 27.07 | ₹166.96 | ₹4519.90 | ₹384 | High |
| 2024 | 41.51 | ₹118.7 | ₹4927.40 | ₹273 | High |
SANOFICONR vs Healthcare Peers — P/B Ratio Comparison
Sanofi Consumer Healthcare P/B 27.2 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |